>> 全站文章索引 >> 第35页:
  • Substitution of the selective serotonin reuptake inhibitors fluoxetine and paroxetine for the discriminative stimulus effects of ethanol in rats - [S. Maurel, Rudy Schreiber, Jean De Vry]
  • smalld-small-Cycloserine and performance under different states of anxiety in healthy volunteers - [Bailey JE, Papadopoulos A, Lingford-Hughes A, Nutt DJ.]
  • Comparison of the effects of venlafaxine, paroxetine and desipramineon the pupillary light reflex in man - [P. Bitsios, E. Szabadi, C. M. Bradshaw]
  • Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex - [Frank P. Bymaster, Wei Zhang, Petra A. Carter, Janice Shaw, Eyassu Chernet, Lee Phebus, David T. Wong, Kenneth W. Perry]
  • ffects of chronic paroxetine administration on measures of aggressive and impulsive responses of adult males with a history of conduct disorder - [Don R. Cherek, Scott D. Lane, Cynthia J. Pietras, Joel L.]
  • Effects of chronic paroxetine administration on measures of aggressive and impulsive responses of adult males with a history of conduct disorder - [Don R. Cherek, Scott D. Lane, Cynthia J. Pietras, Joel L. Steinberg]
  • The selective serotonin reuptake inhibitor paroxetine is effectivein more generalized and in less generalized social anxiety disorder - [Dan J. Stein, Murray B. Stein, Wendy Goodwin, Rajinder Kumar, Brian Hunter]
  • Effects on sleep architecture of pindolol, paroxetine and their combination in healthy volunteers - [Caroline Bell, Sue Wilson, Ann Rich, Jayne Bailey, David Nutt]
  • Symptomatic remission in previously untreated patients with schizophrenia 2-year results from the SOHO study - [Novick D, Haro JM, Suarez D, Lambert M, Lépine JP, Naber D.]
  • Research in child and adolescent psychopharmacology- recent accomplishments and new challenges - [Vitiello B.]
  • The behavioral effects of sertraline, fluoxetine,and paroxetine differ on the differential-reinforcement-of-low-rate72-second operant schedule in the rat - [J. D. Sokolowski, L. S. Seiden]
  • Serotonin transporter occupancy of high-dose selective serotonin reuptake inhibitors during major depressive disorder measured with [11C]DASB positron emission tomography - [Voineskos AN, Wilson AA, Boovariwala A, Sagrati S, Houle S, Rusjan P, Sokolov S, Spencer EP, Ginovart N, Meyer JH.]
  • Effect of adjunctive paroxetine on serum levels and side-effects of tricyclic antidepressants in depressive inpatients - [S. Leucht, H. -J. Hackl, W. Steimer, D. Angersbach, R. Zimmer]
  • Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomized controlled trial - [J.B. Deakin, S. Rahman, P.J. Nestor, J.R. Hodges, B.J. Sahakian]
  • Omega-3 fatty acids and antioxidants in neurological and psychiatric disease - [Mazza M, Pomponi M, Janiri L, Bria P, Mazza S.]
  • long-term changes in social interaction and reward following repeated MDMA administration to adolescent rats without accompanying serotonergic neurotoxicity - [Fone KC, Beckett SR, Topham IA, Swettenham J, Ball M, Maddocks L.]
  • -term changes in social interaction and reward following repeated MDMA administration to adolescent rats without accompanying serotonergic neurotoxicity - [Kevin C. Fone, Simon R. Beckett, Ian A. Topham, Jennifer Swettenham, Melanie Ball, Laura Maddocks]
  • Paroxetine is effective in desensitizing 5-HT1A receptor function in adult offspring exposed prenatally to cocaine - [Zhuo Chen . Julie Tetzlaff . Kumar Sripathirathan .Gonzalo A. Carrasco . Mahalakshmi Shankaran .Louis D. Van De Kar . Nancy A. Muma .George Battaglia]
  • Acute psychomotor, subjective and physiological responses to smoking in depressed outpatient smokers and matched controls - [Malpass D, Higgs S.]
  • Acute effects of venlafaxine and paroxetine on serotonergic transmission in human volunteers - [Richard J. Porter, R. Hamish McAllister-Williams, A. H. Young]
  • he effects of single dose nefazodone and paroxetine upon 5-HT2A binding potential in humans - [J. H. Meyer, R. Cho, S. Kennedy, S. Kapur]
  • Paroxetine combined with a 5-HT 1A receptor antagonist reversed reward deficits observed during amphetamine withdrawal in rats - [Athina Markou, Amanda A. Harrison, Jessica Chevrette, Daniel Hoyer]
  • Differences in platelet serotonin transporter sites between African-American tobacco smokers and non-smokers - [Ashwin A. Patkar, Raman Gopalakrishnan, Wade H. Berrettini, Stephen P. Weinstein, Michael J. Vergare, Frank T. Leone]
  • An exploratory study: The use of paroxetine for methamphetamine craving - [Anne Dekeyne, Alain Gobert, Agnès Auclair, Sylvie Girardon, Mark J. Millan]
  • Antidepressant-like effects in various mice strains in the forced swimming test - [Denis Joseph Paul David, Caroline E. Renard, Pascale Jolliet, Martine Hasco?t, Michel Bourin]
  • Destruction of serotonergic nerve terminals prevents fluoxetine-induced desensitization of hypothalamic 5-HT1A receptors - [D. D]
  • Differential effects of amitriptyline, nefazodone and paroxetine on performance and brain indices of visual selective attention and working memory - [M. van Laar, E. Volkerts, M. Verbaten, S. Trooster, et al. Psychopharmacology. New York: Aug 2002.Vol.162, Iss. 4; pg. 351]
  • Occupancy of brain serotonin transporters during treatment with paroxetine in patients with social phobia: a positron emission tomography study with [11C]McN 5652 - [Justine M. Kent, Jeremy D. Coplan, Ilise Lombardo, Dah-Ren Hwang, Yiyun Huang, Osama Mawlawi, Ronald L. Van Heertum,]
  • Paroxetine as a 5-HT neuroendocrine probe - [H. Kojima, T. Terao, M. Iwakawa, A. Soya, N. Inoue, Y. Shiraishi, Y. Son, S. Soeda, N. Ueda, R. Yoshimura, J.]
  • Serotonin transporter occupancy induced by paroxetine in patients with major depression disorder: a 123I-ADAM SPECT study - [Ana M. Catafau, Victor Perez, Pedro Plaza, Juan-Carlos Pascual, Santiago Bullich, Marina Suarez, Maria M. Penengo, Iluminada Corripio, Dolors Puigdemont, Monica Danus, Javier Perich, Enric Alvarez]
  • Effects of acute and chronic antidepressant treatments on memory performance: a comparison between paroxetine and imipramine Status - [Laurent Naudon, Ma?té Hotte, Thérèse M. Jay]
  • Effect of paroxetine on enhanced contextual fear induced by single prolonged stress in rats - [Terumichi Takahashi, Shigeru Morinobu, Yasuyuki]
  • The selective serotonin re-uptake inhibitors fluvoxamine and paroxetine differ in sexual inhibitory effects after chronic treatment - [Marcel D. Waldinger, Afke van de Plas, Tommy Pattij, Ruud van Oorschot, Lique M. Coolen, Jan G. Veening, Berend Olivier]
  • Treatment-emergent changes in sexual function with selective serotonin reuptake inhibitors as measured with the Rush Sexual Inventory. - [Zajecka J, Mitchell S, Fawcett J]
  • Cardiac vagal control in depression-A critical analysis - [Rottenberg J.]
  • Serotonin transporter inhibitors: synthesis and binding potency of 2′-methyl- and 3′-methyl-6-nitroquipazine - [John M. Gerdes, Steven C. DeFina, Paul A. Wilson and Scott E. Taylor]
  • Basilar artery blood flow velocity changes in patients with panic disorder following 35% carbon dioxide challenge - [Tun? Alk?n, ümit Tural, Elif Onur, Vesile ?ztürk, E. Serap Monkul and Kür?ad Kutluk]
  • Effect of gender on antinociceptive effect of paroxetine in hot plate test in mice - [Erdem N. Duman, Murat Kesim, Mine Kadioglu, Cunay Ulku, Nuri I. Kalyoncu and Ersin Yaris]
  • Depression treatment during outpatient visits by U.S. children and adolescents - [Jun Ma, Ky-Van Lee and Randall S. Stafford]
  • A randomized, double-blind, placebo-controlled trial: Paroxetine controlled release in fibromyalgia - [A.A. Patkar, P.S. Masand, W. Jiang, S. Krulewicz, E. Dube, C. Purcell, C. McMorran and K. Peindl 162.]
  • Retinopathy associated with high-dose interferon alfa-2b therapy - [Charles Hejny, Paul Sternberg, David H. Lawson, Kristen Greiner and Thomas M. Aaberg]
  • The incidence of pancytopenia in patients taking leflunomide alone or with methotrexatey - [McEwen J, Purcell PM, Hill RL, Calcino LJ, Riley CG.]
  • Lamotrigine in patients with epilepsy and comorbid depressive symptoms - [Fakhoury TA, Barry JJ, Mitchell Miller J, Hammer AE, Vuong A.]
  • Paroxetine treatment improves motor symptoms in patients with multiple system atrophy - [Elisabeth Friess, Tania Kuempfel, Sieglinde Modell, Juliane Winkelmann, Florian Holsboer, Marcus Ising and Claudia Trenkwalder]
  • Pilot evaluation of selective serotonin reuptake inhibitor antidepressants in hot flash patients under androgen-deprivation therapy for prostate cancer - [M Naoe1, Y Ogawa1, T Shichijo1, K Fuji1, T Fukagai1 and H Yoshida1]
  • A Qualitative Study of Depression in Primary Care-Missed Opportunities for Diagnosis and Education. - [Saver BG, Van-Nguyen V, Keppel G, Doescher MP.]
  • T3 augmentation of SSRI resistant depression - [Gebrehiwot Abraham, Roumen Milev and J. Stuart Lawson]
  • Medical comorbidity in bipolar disorder reprioritizing unmet needs - [McIntyre RS, Soczynska JK, Beyer JL, Woldeyohannes HO, Law CW, Miranda A, Konarski JZ, Kennedy SH.]
  • Schizoaffective disorder merges schizophrenia and bipolar disorders as one disease - there is no schizoaffective disorder - [Lake CR, Hurwitz N.]
  • Antimicrobial activity of psychotropic drugs: Selective serotonin reuptake inhibitors - [J. L. Munoz-Bellido, S. Munoz-Criado and J. A. Garcìa-Rodrìguez]
  • THE ASCENT OF MOUSE: ADVANCES IN MODELLING HUMAN DEPRESSION AND ANXIETY - [John F. Cryan & Andrew Holmes about the authors]
  • Nursing processes used in the treatment of patients with bipolar disorder - [Goossens PJ, van Achterberg T, Knoppert-van der Klein EA.]
  • Mirtazapine for Pruritus - [Mellar P. Davis, Jan L. Frandsen, Declan Walsh, Steven Andresen and Sandy Taylor]
  • Proteomics-driven progress in neurodegeneration research - [Fountoulakis M, Kossida S.]
  • The Proinflammatory Cytokines Interleukin-1beta and Tumor Necrosis Factor-Alpha Activate Serotonin Transporters - [Zhu CB, Blakely RD, Hewlett WA.]
  • The Proinflammatory Cytokines Interleukin-1beta and Tumor Necrosis Factor-Alpha Activate Serotonin Transporters - [Chong-Bin Zhu1, Randy D Blakely1,2,3 and William A Hewlett1,2]
  • Therapy Insight: fibromyalgia?—a different type of pain needing a different type of treatment - [Dina Dadabhoy, Daniel J Clauw]
  • Investigation of an attentional bias for fear-related material in obsessive-compulsive checkers - [Moritz S, von Mühlenen A.]
  • Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension - [J.-M. LAUNAY1, P. HERVé2, K. PEOC’H1, C. TOURNOIS1, J. CALLEBERT1, C.G. NEBIGIL3,N. ETIENNE3, L. DROUET1, M. HUMBERT4,G.SIMONNEAU4 & L. MAROTEAUX3]
  • A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care - [Community Pharmacology Services Ltd (CPS), Clydebank, Glasgow, UK. cps@cpsresearch.co.uk]
  • Changes on the Temperament and Character Inventory after paroxetine treatment in volunteers with generalized anxiety disorder. - [Allgulander C, Cloninger CR, Przybeck TR, Brandt L]
  • Functional and pharmacological characterization of the modulatory role of serotonin on the firing activity of locus coeruleus norepinephrine neurons - [Steven T. Szabo and Pierre Blier]
  • Paroxetine Decreases Respiratory Irregularity of Linear and Nonlinear Measures of Respiration in Patients with Panic Disorder - [Vikram Kumar Yeragani, Radhakrishna Rao, Manuel Tancer, Thomas Uhde]
  • Early Changes in Prefrontal Activity Characterize Clinical Responders to Antidepressants - [Ian A Cook MD, Andrew F Leuchter MD, Melinda Morgan Ph.D, Elise Witte Ph.D, William F Stubbeman MD, Michelle Abrams RN, Susan Rosenberg MSN and Sebastian HJ Uijtdehaage Ph.D]
  • Cerebrospinal Fluid Corticotropin-Releasing Factor Concentration is Associated with Pain but not Fatigue Symptoms in Patients with Fibromyalgia - [Samuel A McLean1, David A Williams2, Phyllis K Stein3, Richard E Harris2, Angela K Lyden2, Gail Whalen4, Karen M Park5, Israel Liberzon6, Ananda Sen7, Richard H Gracely2, James N Baraniuk4 and Daniel J Clauw2]
  • Validation of a revised visual analog scale for premenstrual mood symptoms: results from prospective and retrospective trials. - [Steiner M, Streiner DL]
  • Longitudinal Assessment of Depression and Cognitive Impairment Following Stroke - [Downhill JE, Robinson RG.]
  • Longitudinal Assessment of Depression and Cognitive Impairment Following Stroke - [DOWNHILL, J. ACK; ROBINSON, R. OBERT]
  • The Phosphodiesterase Type 4 Inhibitor, Rolipram, Enhances Glucocorticoid Receptor Function - [Andrew H Miller MD, Gerald J Vogt Ph.D and Bradley D Pearce Ph.D]
  • Course of Illness in Psychotic Mania Is Mood Incongruence Important - [Gaudiano BA, Uebelacker LA, Miller IW.]
  • Determinants of sexual disability and dissatisfaction in female patients with rheumatoid arthritis - [Abdel-Nasser AM, Ali EI.]
  • Localized Orbitofrontal and Subcortical Metabolic Changes and Predictors of Response to Paroxetine Treatment in Obsessive-Compulsive Disorder - [Sanjaya Saxena1 MD, Arthur L Brody1 MD, Karron M Maidment1 RN, Jennifer J Dunkin1 Ph.D, Mark Colgan2 ME, Shervin Alborzian2, Michael E Phelps2 Ph.D and Lewis R Baxter Jr1,2,3 MD]
  • Ketamine Depresses Myocardial Contractility as Evaluated by the Preload Recruitable Stroke Work Relationship in Chronically Instrumented Dogs with Autonomic Nervous System Blockade - [Pagel, Paul S.; Kampine, John P.; Schmeling, William T.; Warltier, David C.]
  • Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters - [Carmine M Pariante, Andrew Makoff, Simon Lovestone, Susan Feroli, Alexandra Heyden, Andrew H Miller, Robert W Kerwin]
  • The question of feedback at the somadendritic region and antidepressant drug action - [Stanley Kalsner]
  • Behavioral Teratogenicity Induced by Nonforced Maternal Nicotine Consumption - [Rodrigo Paz1,2,3, Brigg Barsness4, Trevor Martenson4, Daniel Tanner1 and Andrea M Allan1]
  • Hormone replacement therapy and antidepressant prescription patterns: a reciprocal relationship - [Roger S McIntyre, Jakub Z Konarski, Sophie Grigoriadis, Nancy C Fan, et al]
  • Persistent pulmonary hypertension of the newborn and maternal use of SSRIs - [Eric Wooltorton]
  • Determinants and consequences of post-stroke depression - [Gainotti, Guido; Marra, Camillo]
  • A Review of Postpartum Depression for the Primary Care Physician - [Dr. D.A. Seehusen, Department of Family Practice, Madigan Army Medical Center, Ft. Lewis, WA 98431; United States. E-Mail: dean.seehusen@nw.amedd.army.mil.]
  • Binding of [(3)H]lysergic acid diethylamide to serotonin 5-HT(2A) receptors and of [(3)H]paroxetine to serotonin uptake sites in platelets from healthy children, adolescents and adults. - [Sigurdh J, Spigset O, Allard P, Mjorndal T, Hagglof B]
  • Differential effects of paroxetine on raphe and cortical 5-HT1A binding: A PET study in monkeys - [Giampiero Giovacchini, Lixin Lang, Ying Ma, Peter Herscovitch, William C. Eckelman and Richard E. Carson]
  • Morphine, cocaine and antidepressant induced motivational activity and midbrain dopaminergic neurotransmission - [Paul N Deslandes, David M Pache, Paul Buckland and Robert D.E Sewell]
  • 5-HT2A promoter polymorphism -1438G/A in children and adolescents with obsessive-compulsive disorders - [S Walitza1, C Wewetzer1, A Warnke1, M Gerlach1, F Geller5, G Gerber2, T G?rg5, B Herpertz-Dahlmann3, E Schulz4, H Remschmidt2, J Hebebrand2 and A Hinney2]
  • Effects of long-term lithium treatment on monoaminergic functions in major depression - [Aram El Khoury, Lars Johnson, Anna ?berg-Wistedt and Rigmor Stain-Malmgren]
  • Plasma concentrations of anxiolytic neuroactive steroids in men with panic disorder - [Francesca Brambilla, Carmen Mellado, Alessandra Alciati, Maria Giuseppina Pisu, Robert H. Purdy, Stefano Zanone, Giulia Perini, Mariarosa Serra and Giovanni Biggio]
  • Postictal cardiovascular response predicts therapeutic efficacy of electroconvulsive therapy for depression - [Azuma H, Fujita A, Sato K, Arahata K, Otsuki K, Hori M, Mochida Y, Uchida M, Yamada T, Akechi T, Furukawa TA.]
  • Effects of repeated phencyclidine treatment on serotonin transporter in rat brain - [Takafumi Hori, Shuzo Abe, Atsuomi Baba, Toshihito Suzuki and Hiroyasu Shiraishi]
  • Examination of the decline in symptoms of anxiety and depression in generalized anxiety disorder impact of anxiety sensitivity on response to pharmacotherapy - [Olatunji BO, Feldman G, Smits JA, Christian KM, Zalta AK, Pollack MH, Simon NM.]
  • Drug interactions in the hematopoietic stem cell transplant (HSCT) recipient: what every transplanter needs to know - [H L Leather1]
  • Zebra mussel spawning is induced in low concentrations of putative serotonin reuptake inhibitors - [Peter P Fong]
  • FURTHER CHARACTERIZATION OF A RAT MODEL OF VARICELLA ZOSTER VIRUS–ASSOCIATED PAIN:RELATIONSHIP BETWEEN MECHANICAL HYPERSENSITIVITY AND ANXIETY-RELATED BEHAVIOR,AND THE INFLUENCE OF ANALGESIC DRUGS - [Hasnie FS, Breuer J, Parker S, Wallace V, Blackbeard J, Lever I, Kinchington PR, Dickenson AH, Pheby T, Rice AS.]
  • A novel antipsychotic,perospirone,has antiserotonergic and antidopaminergic effects in human brain:findings from neuroendocrine challenge tests - [Iwakawa M, Terao T, Soya A, Kojima H, Inoue Y, Ueda N, Yoshimura R, Nakamura J]
  • Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial-development,methodology,and rationale - [Keefe RS, Mohs RC, Bilder RM, Harvey PD, Green MF, Meltzer HY, Gold JM, Sano M.]
  • Cognitive Dysfunction Relates to Subjective Report of Mental Fatigue in Patients with Chronic Fatigue Syndrome - [Lucile Capuron1, Leonie Welberg1, Christine Heim1, Dieter Wagner2, Laura Solomon2,4, Dimitris A Papanicolaou3,5, R Cameron Craddock2, Andrew H Miller1 and William C Reeves2]
  • Ghrelin concentrations and cardiac vagal tone are decreased after pharmacologic and cognitive–behavioral treatment in patients with bulimia nervosa - [Muneki Tanaka, Toshihiro Nakahara, Tetsuro Muranaga, Shinya Kojima, Daisuke Yasuhara, Hiroaki Ueno, Masamitsu Nakazato and Akio Inui]
  • Antidepressants and suicidal behavior in bipolar disorder - [McElroy SL, Kotwal R, Kaneria R, Keck PE.]
  • Treating Patients Comorbid depression,anxiety somatic illnesses - [Dolnak DR.]
  • Is GSK guilty of fraud? - [Anonymous]
  • Comparison of the anticholinergic effects of the serotonergic antidepressants, paroxetine, fluvoxamine and clomipramine - [Jun Fujishiro, Taiichiro Imanishi, Kaname Onozawa and Masaki Tsushima]


    • 分页: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 [35] 36 37 38 39 40
    41 42 43 44 45 46 47 48 49 50